paris saponin vii has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, X; Liu, XW; Liu, Y; Peng, P; Ren, YL; Shen, J; Si, Y; Wan, F; Xiang, YC; Yu, QQ; Zhang, L; Zhang, T; Zhao, HZ | 1 |
| Jin, H; Li, X; Li, Y; Mei, Q; Niu, Y; Sun, Y; Tang, T; Xie, M | 1 |
2 other study(ies) available for paris saponin vii and Breast Cancer
| Article | Year |
|---|---|
Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells.
Topics: Animals; Autophagy; Breast Neoplasms; Cell Proliferation; Female; Hippo Signaling Pathway; Humans; Mice; Molecular Docking Simulation; Protein Serine-Threonine Kinases; Saponins | 2022 |
Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Phytotherapy; Saponins; Trillium; Tumor Burden | 2019 |